The 2023 weak shares of Darmstadt-based Merck approached their low since May 2021 on Tuesday. With a discount of 2.7 percent to 137.40 euros, the price of the chemical and pharmaceutical company fell.
Persistently weak business in the Laboratory division and with semiconductor materials have spoiled another quarter for the Darmstadt-based Merck Group. This was exacerbated by increased negative.
Persistently weak business in the Laboratory division and with semiconductor materials have spoiled another quarter for the Darmstadt-based Merck Group. This was exacerbated by increased negative.
The Biden administration has inked a deal with the North American arm of a German pharmaceutical company to build a plant in Wisconsin that will produce lateral flow membranes used in rapid diagnostic test kits, including ones used to detect COVID-19